Statins and therapy of Alzheimer's disease: questions of efficacy versus trial design

Recent trials of statins produced no benefit for subjects with Alzheimer's disease. These negative studies add to a growing list of negative clinical trials. These data point to a need for reevaluating the pathophysiology of late-onset Alzheimer's disease. Late-onset Alzheimer's disea...

Descripción completa

Detalles Bibliográficos
Autor principal: Wolozin, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471428/
https://www.ncbi.nlm.nih.gov/pubmed/22264400
http://dx.doi.org/10.1186/alzrt101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471428/
https://www.ncbi.nlm.nih.gov/pubmed/22264400
http://dx.doi.org/10.1186/alzrt101

Ejemplares similares